Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2019 3
2020 4
2021 3
2022 4
2023 6
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Dupilumab increases aspirin tolerance in NSAID-exacerbated respiratory disease.
Schneider S, Poglitsch K, Morgenstern C, Quint T, Gangl K, Sinz C, Bartosik T, Campion NJ, Liu DT, Landegger LD, Tu A, Stanek V, Rocha-Hasler M, Bangert C, Eckl-Dorna J. Schneider S, et al. Among authors: stanek v. Eur Respir J. 2023 Mar 16;61(3):2201335. doi: 10.1183/13993003.01335-2022. Print 2023 Mar. Eur Respir J. 2023. PMID: 36549708 Free PMC article.
Nasal IL-13 production identifies patients with late-phase allergic responses.
Campion NJ, Villazala-Merino S, Thwaites RS, Stanek V, Killick H, Pertsinidou E, Zghaebi M, Toth J, Fröschl R, Perkmann T, Gangl K, Schneider S, Ristl R, Scott IC, Cohen ES, Molin M, Focke-Tejkl M, Regelsberger G, Hansel TT, Valenta R, Niederberger-Leppin V, Eckl-Dorna J. Campion NJ, et al. Among authors: stanek v. J Allergy Clin Immunol. 2023 Nov;152(5):1167-1178.e12. doi: 10.1016/j.jaci.2023.06.026. Epub 2023 Aug 1. J Allergy Clin Immunol. 2023. PMID: 37536510 Free article. Clinical Trial.
Dupilumab reduces symptom burden in allergic rhinitis and suppresses allergen-specific IgE production.
Campion NJ, Doralt A, Lupinek C, Berger M, Poglitsch K, Brugger J, Quint T, Gangl K, Sinz C, Bartosik T, Liu DT, Landegger LD, Tu A, Stanek V, Berger U, Bangert C, Schneider S, Eckl-Dorna J. Campion NJ, et al. Among authors: stanek v. Allergy. 2023 Jun;78(6):1687-1691. doi: 10.1111/all.15653. Epub 2023 Feb 3. Allergy. 2023. PMID: 36691369 No abstract available.
Using mass cytometry for the analysis of samples of the human airways.
Rocha-Hasler M, Müller L, Wagner A, Tu A, Stanek V, Campion NJ, Bartosik T, Zghaebi M, Stoshikj S, Gompelmann D, Zech A, Mei H, Kratochwill K, Spittler A, Idzko M, Schneider S, Eckl-Dorna J. Rocha-Hasler M, et al. Among authors: stanek v. Front Immunol. 2022 Dec 12;13:1004583. doi: 10.3389/fimmu.2022.1004583. eCollection 2022. Front Immunol. 2022. PMID: 36578479 Free PMC article.
Zerumbone acts as a radiosensitizer in head and neck squamous cell carcinoma.
Schnoell J, Stanisz I, Jank BJ, Stanek V, Schmid R, Brunner M, Heiduschka G, Kotowski U. Schnoell J, et al. Among authors: stanek v. Invest New Drugs. 2022 Apr;40(2):224-231. doi: 10.1007/s10637-021-01190-7. Epub 2021 Oct 6. Invest New Drugs. 2022. PMID: 34613571 Free PMC article.
Differences in men and women suffering from CRSwNP and AERD in quality of life.
Bartosik TJ, Liu DT, Campion NJ, Villazala-Merino S, Janik S, Dahm V, Mueller CA, Vyskocil E, Stanek V, Quint T, Bangert C, Eckl-Dorna J, Schneider S. Bartosik TJ, et al. Among authors: stanek v. Eur Arch Otorhinolaryngol. 2021 May;278(5):1419-1427. doi: 10.1007/s00405-020-06418-5. Epub 2020 Oct 15. Eur Arch Otorhinolaryngol. 2021. PMID: 33063145 Free PMC article.
20 results